Lantheus Holdings, Inc. SEC filings LNTH
Lantheus Holdings, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Aug 5, 2016. Its latest annual report, Form ARS, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Sep 2, 2026 | — |
| S-8 | Employee stock plan registration | Aug 21, 2024 | — |
| S-8 | Employee stock plan registration | May 16, 2023 | — |
| S-8 | Employee stock plan registration | May 12, 2022 | — |
| S-8 | Employee stock plan registration | Aug 4, 2021 | — |
| S-8 | Employee stock plan registration | Jun 26, 2020 | — |
| 424B3 | Prospectus | May 14, 2020 | — |
| 424B3 | Prospectus | Mar 19, 2020 | — |
| S-4/A | Filing | Mar 16, 2020 | — |
| S-4 | Registration for a merger or exchange | Nov 12, 2019 | — |
| S-8 | Employee stock plan registration | Jul 31, 2019 | — |
| S-8 | Employee stock plan registration | Aug 18, 2017 | — |
| S-8 | Employee stock plan registration | Aug 18, 2017 | — |
| 424B7 | Filing | Jun 16, 2017 | — |
| 424B7 | Filing | Jun 14, 2017 | — |
| 424B7 | Filing | May 5, 2017 | — |
| 424B7 | Filing | May 3, 2017 | — |
| 424B7 | Filing | Mar 15, 2017 | — |
| 424B5 | Prospectus supplement | Mar 13, 2017 | — |
| S-3 | Shelf registration | Dec 12, 2016 | — |
| 424B5 | Prospectus supplement | Nov 17, 2016 | — |
| 424B5 | Prospectus supplement | Nov 16, 2016 | — |
| S-3MEF | Filing | Nov 15, 2016 | — |
| S-8 | Employee stock plan registration | Oct 31, 2016 | — |
| 424B5 | Prospectus supplement | Sep 12, 2016 | — |
| 424B5 | Prospectus supplement | Sep 8, 2016 | — |
| S-3 | Shelf registration | Aug 5, 2016 | — |
Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- LNTH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bedford, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1521036
- Former names
- Lantheus MI Holdings, Inc. (until May 23, 2014)
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
- Alpha Teknova, Inc. TKNO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.